VitaNova Life Sciences (VNOV) Short term Debt (2017 - 2025)

VitaNova Life Sciences (VNOV) reported Short term Debt of $102000.0 for Q1 2025, up 135.17% on a YoY basis from $43372.0 in Q1 2024, and down 20.31% quarter-over-quarter from $128000.0 in Q4 2024.

VitaNova Life Sciences (VNOV) Short term Debt (2017 - 2025) Analysis & Trends

VitaNova Life Sciences has reported Short term Debt for 9 years, with the latest figure at $102000.0 in Q1 2025.

  • For the quarter ending Q1 2025, Short term Debt rose 135.17% year-over-year to $102000.0; the trailing twelve-month figure through Jan 2025 stood at $102000.0 (up 135.17% YoY), and the FY2024 full-year result was $3000.0, down 81.37% from the prior year.
  • Short term Debt for Q1 2025 stood at $102000.0, down from $128000.0 in the prior quarter.
  • The five-year high for Short term Debt was $146107.0 in Q1 2021, with the low at $3000.0 in Q2 2024.
  • Historically, Short term Debt has averaged $48874.9 across 5 years, with a median of $16100.0 in 2023.
  • Annual changes were most pronounced in 2022 — Short term Debt sank 91.72% — and 2024, when it soared 688.32%.
  • VitaNova Life Sciences' Short term Debt stood at $12100.0 in 2021, then changed by 0.0% to $12100.0 in 2022, then surged by 34.19% to $16237.0 in 2023, then soared by 688.32% to $128000.0 in 2024, then retreated by 20.31% to $102000.0 in 2025.
  • The last three Short term Debt figures came in at $102000.0 (Q1 2025), $128000.0 (Q4 2024), and $55600.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn
10 VitaNova Life Sciences - - 316,343.00

Historic Data

Download Data
DateValue
Jan 31, 2025 102,000.00
Oct 31, 2024 128,000.00
Jul 31, 2024 55,600.00
Apr 30, 2024 3,000.00
Jan 31, 2024 43,372.00
Oct 31, 2023 16,237.00
Apr 30, 2023 16,100.00
Jan 31, 2023 16,100.00
Oct 31, 2022 12,100.00
Jul 31, 2022 12,100.00
Apr 30, 2022 12,100.00
Jan 31, 2022 12,100.00
Oct 31, 2021 12,100.00
Apr 30, 2021 146,107.00
Jan 31, 2021 146,107.00
Oct 31, 2020 134,392.00
Jul 31, 2020 103,821.00
Apr 30, 2020 103,821.00
Jan 31, 2020 89,024.00
Oct 31, 2019 81,809.00